Redefining the Target: Chemotherapeutics as Antiangiogenics

This publication has 91 references indexed in Scilit:

• Marked Induction of the IAP Family Antiapoptotic Proteins Survivin and XIAP by VEGF in Vascular Endothelial Cells
  Biochemical and Biophysical Research Communications, 1999
• Hemmung der Tumorneoangiogenese und Induktion von Apoptose als Eigenschaften von Docetaxel (Taxotere®)
  Mund-,Kiefer- und Gesichtschirurgie, 1999
• Tumor Vascularity—A Novel Prognostic Factor in Advanced Cervical Carcinoma
  Gynecologic Oncology, 1995
• “Classical” CMF versus a 3-weekly intravenous CMF schedule in postmenopausal patients with advanced breast cancer: An EORTC Breast Cancer Co-operative Group Phase III Trial (10808)
  European Journal of Cancer and Clinical Oncology, 1991
• What Is the Evidence That Tumors Are Angiogenesis Dependent?
  JNCI Journal of the National Cancer Institute, 1990
• Inhibition of angiogenesis by the antineoplastic agents mitoxantrone and bisantrene
  Biochemical and Biophysical Research Communications, 1986
• Neovascularization in human cutaneous melanoma: A quantitative morphological and Doppler ultrasound study
  European Journal of Cancer and Clinical Oncology, 1986
• Inhibitory effects of anti-angiogenic agents on neovascularization and growth of the chorioallantoic membrane (CAM). — The possibility of a new CAM assay for angiogenesis inhibition
  Experimental pathology, 1986
• The chick embryo chorioallantoic membrane as a bioassay for angiogenesis factors: Reactions induced by carrier materials
  Experimentelle Pathologie, 1978
• Tumor Angiogenesis: Therapeutic Implications
  New England Journal of Medicine, 1971